The authors propose that a mitochondrial complex I defect is associated with the degeneration of TM cells in patients with POAG, and antioxidants and MPT inhibitors can reduce the progression of this condition.
No takes yet. Share an insight, caveat, or question.
He et al. (2008) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: